Emerging Technologies in the Biopsy Device Market By 2024 to 2034

 


According to a recent study by Future Market Insights (FMI), the global biopsy device market is projected to experience steady, moderate growth over the coming decade. Valued at approximately USD 2,274.1 million in 2024, the market is expected to expand at a CAGR of 3.7% from 2024 to 2034, reaching an anticipated valuation of USD 3,270.4 million by the end of the forecast period.

As healthcare systems worldwide continue to invest in early diagnostic tools, demand for biopsy devices is on an upward trajectory, with the market expected to grow 1.4 times its current size over the next ten years. Key factors driving this growth include advances in minimally invasive biopsy techniques, rising incidence of cancer and other chronic diseases requiring diagnostic biopsies, and technological innovations aimed at improving patient outcomes and diagnostic accuracy.

Future Market Insights’ analysis suggests that this positive yet moderate growth trend will be supported by strategic investments in research and development within the biopsy device ecosystem, especially those focused on enhancing precision and patient comfort. This report provides critical insights for stakeholders aiming to leverage upcoming opportunities in the biopsy device market and emphasizes the sector's readiness to support the evolving demands of healthcare providers and patients alike.

Opportunities for Growth:

As healthcare providers increasingly prioritize early detection and preventive healthcare, opportunities for growth within the biopsy device market are abundant. Medical tourism, which has seen a rise in Thailand due to its cost-effective and high-quality medical services, also presents a unique opportunity for market expansion.

Industry Outlook:

The next decade is poised to witness strong collaborations between local healthcare providers and international medical device manufacturers, ensuring that advanced biopsy technologies are more widely available across Thailand. Moreover, the country's aging population and the growing focus on non-communicable diseases will further fuel demand for diagnostic solutions such as biopsy devices.

Market Highlights:

  • India: Expected to have the highest growth rate, with a CAGR of 5.8% among all countries.
  • France: Leading the European market with a forecasted growth rate of 4.3%.
  • Needle Biopsy Market Segment: Projected to secure the largest market share of 36.6% by 2024.
  • Medical Diagnosis: The largest application segment, holding 61.3% of the market share by 2024.

Challenges and Recommendations:

Ethical and legal considerations surrounding biopsy procedures present significant challenges. Adherence to strict procedural standards is essential to ensure clean practices and maintain market integrity.

Biopsy Device Trends: Find Out More in Our Comprehensive Report Filled with Key Insights!

Competitive Landscape:

The global biopsy device market is highly competitive, with several key players strengthening their positions through strategic initiatives:

  • B. Braun Melsungen AG acquired Intermedt Medizin & Technik GmbH in March 2022, diversifying the Avitum division’s product portfolio.
  • Becton, Dickinson, and Company collaborated with GOCC in March 2024 to advance bloodstream infection testing and expand operations in Poland.

Key Companies in the Market:

  • CR Bard
  • Becton, Dickinson, and Company
  • B. Braun Melsungen AG
  • Hologic Inc.
  • Cook Medical
  • Devicor Medical Products Inc.
  • Argon Medical Inc.

Market Segmentation:

  • By Product Type: Guidance System, Needles, Guns, Reagents and Kits, Others
  • By Application: Medical Diagnosis, Scientific Research
  • By End Use: Hospital, Specialized Oncology Centres, Diagnostic Centers, Research Institutes
By Region: North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, The Middle East and Africa

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more